Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Antigens"" wg kryterium: Temat


Tytuł:
Contribution of HLA class I (A, B, C) and HLA class II (DRB1, DQA1, DQB1) alleles and haplotypes in exploring ethnic origin of central Tunisians.
Autorzy:
Ben Bnina A; Hematology Laboratory, Sahloul University Hospital, Sousse, Tunisia.; Faculty of Pharmacy, University of Monastir, Monastir, Tunisia.
Yessine A; Biochemistry Laboratory, Béchir Hamza Children's Hospital, Bab Saadoun Square, 1007, Tunis, Tunisia. .; Department of Educational Sciences, University of Jendouba, Higher Institute of Applied Studies in Humanity Le Kef, Kef, Tunisia. .
El Bahri Y; Hematology Laboratory, Sahloul University Hospital, Sousse, Tunisia.; Faculty of Medicine, University of Sousse, Sousse, Tunisia.
Chouchene S; Hematology Laboratory, Fatouma Bourguiba Teaching Hospital, Sousse, Tunisia.; Faculty of Pharmacy, University of Monastir, Monastir, Tunisia.
Ben Lazrek N; Hematology Laboratory, Sahloul University Hospital, Sousse, Tunisia.
Mimouna M; Hematology Laboratory, Sahloul University Hospital, Sousse, Tunisia.
Mlika Z; Hematology Laboratory, Sahloul University Hospital, Sousse, Tunisia.
Messoudi A; Hematology Laboratory, Sahloul University Hospital, Sousse, Tunisia.
Zellama D; Nephrology Department, Sahloul University Hospital, Sousse, Tunisia.; Faculty of Medicine, University of Sousse, Sousse, Tunisia.
Sahtout W; Nephrology Department, Sahloul University Hospital, Sousse, Tunisia.; Faculty of Medicine, University of Sousse, Sousse, Tunisia.
Bouatay A; Hematology Laboratory, Sahloul University Hospital, Sousse, Tunisia.; Faculty of Pharmacy, University of Monastir, Monastir, Tunisia.
Pokaż więcej
Źródło:
BMC medical genomics [BMC Med Genomics] 2024 Feb 29; Vol. 17 (1), pp. 65. Date of Electronic Publication: 2024 Feb 29.
Typ publikacji:
Journal Article
MeSH Terms:
Polymorphism, Genetic*
HLA-C Antigens*/genetics
North African People*
Humans ; Haplotypes ; HLA-DRB1 Chains/genetics ; Alleles ; Gene Frequency ; HLA-B Antigens/genetics ; HLA-A Antigens/genetics
Czasopismo naukowe
Tytuł:
Polymorphism of HLA and Susceptibility of Breast Cancer.
Autorzy:
Aboulaghras S; Laboratory of Human Pathologies Biology, Faculty of Sciences, Mohammed V University in Rabat, 10106 Rabat, Morocco.
Khalid A; Substance Abuse and Toxicology Research Center, Jazan University, 114 Jazan, Saudi Arabia.; Medicinal and Aromatic Plants Research Institute, National Center for Research, 11111 Khartoum, Sudan.
Makeen HA; Pharmacy Practice Research Unit, Clinical Pharmacy Department, Faculty of Pharmacy, Jazan University, 82822 Jazan, Saudi Arabia.
Alhazmi HA; Substance Abuse and Toxicology Research Center, Jazan University, 114 Jazan, Saudi Arabia.; Department of Pharmaceutical Chemistry and Pharmacognosy, College of Pharmacy, Jazan University, 82822, Jazan, Saudi Arabia.
Albratty M; Department of Pharmaceutical Chemistry and Pharmacognosy, College of Pharmacy, Jazan University, 82822, Jazan, Saudi Arabia.
Mohan S; Substance Abuse and Toxicology Research Center, Jazan University, 114 Jazan, Saudi Arabia.; School of Health Sciences, University of Petroleum and Energy Studies, Dehradun, 248001 Uttarakhand, India.
Goh BH; Sunway Biofunctional Molecules Discovery Centre, School of Medical and Life Sciences, Sunway University Malaysia, Bandar Sunway, 47500 Selangor Darul Ehsan, Malaysia.; College of Pharmaceutical Sciences, Zhejiang University, 310058 Hangzhou, Zhejiang, China.
Yeo CI; Sunway Biofunctional Molecules Discovery Centre, School of Medical and Life Sciences, Sunway University Malaysia, Bandar Sunway, 47500 Selangor Darul Ehsan, Malaysia.
Tan YS; Sunway Biofunctional Molecules Discovery Centre, School of Medical and Life Sciences, Sunway University Malaysia, Bandar Sunway, 47500 Selangor Darul Ehsan, Malaysia.
Bouyahya A; Laboratory of Human Pathologies Biology, Faculty of Sciences, Mohammed V University in Rabat, 10106 Rabat, Morocco.
Pokaż więcej
Źródło:
Frontiers in bioscience (Landmark edition) [Front Biosci (Landmark Ed)] 2024 Feb 05; Vol. 29 (2), pp. 55.
Typ publikacji:
Journal Article; Review
MeSH Terms:
HLA-G Antigens*/genetics
Breast Neoplasms*/genetics
Humans ; Female ; HLA-E Antigens ; Polymorphism, Genetic ; Histocompatibility Antigens Class II/genetics
Czasopismo naukowe
Tytuł:
T-FINDER: A highly sensitive, pan-HLA platform for functional T cell receptor and ligand discovery.
Autorzy:
Cetin M; BioMed X GmbH, Im Neuenheimer Feld 515, 69120 Heidelberg, Germany.
Pinamonti V; BioMed X GmbH, Im Neuenheimer Feld 515, 69120 Heidelberg, Germany.; Faculty of Biosciences, Heidelberg University, 69120 Heidelberg, Germany.
Schmid T; BioMed X GmbH, Im Neuenheimer Feld 515, 69120 Heidelberg, Germany.
Boschert T; Faculty of Biosciences, Heidelberg University, 69120 Heidelberg, Germany.; DKTK CCU Neuroimmunology and Brain Tumor Immunology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.; Helmoltz Institute for Translational Oncology (HI-TRON), Heidelberg, Germany.
Mellado Fuentes A; BioMed X GmbH, Im Neuenheimer Feld 515, 69120 Heidelberg, Germany.
Kromer K; BioMed X GmbH, Im Neuenheimer Feld 515, 69120 Heidelberg, Germany.; Faculty of Biosciences, Heidelberg University, 69120 Heidelberg, Germany.
Lerner T; BioMed X GmbH, Im Neuenheimer Feld 515, 69120 Heidelberg, Germany.
Zhang J; BioMed X GmbH, Im Neuenheimer Feld 515, 69120 Heidelberg, Germany.
Herzig Y; BioMed X GmbH, Im Neuenheimer Feld 515, 69120 Heidelberg, Germany.
Ehlert C; Heidelberg Institute for Theoretical Studies (HITS gGmbH), 69118 Heidelberg, Germany.
Hernandez-Hernandez M; BioMed X GmbH, Im Neuenheimer Feld 515, 69120 Heidelberg, Germany.
Samaras G; BioMed X GmbH, Im Neuenheimer Feld 515, 69120 Heidelberg, Germany.
Torres CM; BioMed X GmbH, Im Neuenheimer Feld 515, 69120 Heidelberg, Germany.
Fisch L; BioMed X GmbH, Im Neuenheimer Feld 515, 69120 Heidelberg, Germany.; Faculty of Biosciences, Heidelberg University, 69120 Heidelberg, Germany.
Dragan V; BioMed X GmbH, Im Neuenheimer Feld 515, 69120 Heidelberg, Germany.; Faculty of Biosciences, Heidelberg University, 69120 Heidelberg, Germany.
Kouwenhoven A; Janssen Research and Development, Beerse, Belgium.
Van Schoubroeck B; Janssen Research and Development, Beerse, Belgium.
Wils H; Janssen Research and Development, Beerse, Belgium.
Van Hove C; Janssen Research and Development, Beerse, Belgium.
Platten M; DKTK CCU Neuroimmunology and Brain Tumor Immunology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.; Helmoltz Institute for Translational Oncology (HI-TRON), Heidelberg, Germany.; Department of Neurology, Medical Faculty Mannheim, MCTN Heidelberg University, Mannheim, Germany.
Green EW; DKTK CCU Neuroimmunology and Brain Tumor Immunology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.; Department of Neurology, Medical Faculty Mannheim, MCTN Heidelberg University, Mannheim, Germany.
Stevenaert F; Janssen Research and Development, Beerse, Belgium.
Felix NJ; Janssen Research and Development, Spring House, PA, USA.
Lindner JM; BioMed X GmbH, Im Neuenheimer Feld 515, 69120 Heidelberg, Germany.
Pokaż więcej
Źródło:
Science advances [Sci Adv] 2024 Feb 02; Vol. 10 (5), pp. eadk3060. Date of Electronic Publication: 2024 Feb 02.
Typ publikacji:
Journal Article
MeSH Terms:
Histocompatibility Antigens Class I*
Receptors, Antigen, T-Cell*/metabolism
Humans ; Ligands ; HLA Antigens ; Histocompatibility Antigens Class II
Czasopismo naukowe
Tytuł:
Accurate modeling of peptide-MHC structures with AlphaFold.
Autorzy:
Mikhaylov V; The Simons Center for Systems Biology, Institute for Advanced Study, 1 Einstein Drive, Princeton, NJ 08540, USA. Electronic address: .
Brambley CA; Department of Chemistry and Biochemistry and the Harper Cancer Research Institute, University of Notre Dame, Notre Dame, IN 46556, USA.
Keller GLJ; Department of Chemistry and Biochemistry and the Harper Cancer Research Institute, University of Notre Dame, Notre Dame, IN 46556, USA.
Arbuiso AG; Department of Chemistry and Biochemistry and the Harper Cancer Research Institute, University of Notre Dame, Notre Dame, IN 46556, USA.
Weiss LI; Department of Chemistry and Biochemistry and the Harper Cancer Research Institute, University of Notre Dame, Notre Dame, IN 46556, USA.
Baker BM; Department of Chemistry and Biochemistry and the Harper Cancer Research Institute, University of Notre Dame, Notre Dame, IN 46556, USA.
Levine AJ; The Simons Center for Systems Biology, Institute for Advanced Study, 1 Einstein Drive, Princeton, NJ 08540, USA.
Pokaż więcej
Źródło:
Structure (London, England : 1993) [Structure] 2024 Feb 01; Vol. 32 (2), pp. 228-241.e4. Date of Electronic Publication: 2023 Dec 18.
Typ publikacji:
Journal Article
MeSH Terms:
Histocompatibility Antigens Class II*/chemistry
Histocompatibility Antigens Class II*/metabolism
Peptides*/chemistry
Protein Binding ; T-Lymphocytes/metabolism ; Histocompatibility Antigens Class I/chemistry ; Histocompatibility Antigens Class I/metabolism
Czasopismo naukowe
Tytuł:
The Role of the CD28 Family Receptors in T-Cell Immunomodulation.
Autorzy:
Ciesielska-Figlon K; Department of Physiopathology, Medical University of Gdansk, 80-211 Gdansk, Poland.
Lisowska KA; Department of Physiopathology, Medical University of Gdansk, 80-211 Gdansk, Poland.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2024 Jan 20; Vol. 25 (2). Date of Electronic Publication: 2024 Jan 20.
Typ publikacji:
Journal Article; Review
MeSH Terms:
CD28 Antigens*
T-Lymphocytes*
CTLA-4 Antigen ; Programmed Cell Death 1 Receptor ; Antigens, CD ; Immunity ; Immunomodulation ; Antigens, Differentiation, T-Lymphocyte ; Lymphocyte Activation
Czasopismo naukowe
Tytuł:
HLA Polymorphisms and Clinical Manifestations in IgA Vasculitis.
Autorzy:
Held M; Department of Pediatrics, University Hospital Centre Zagreb, University of Zagreb School of Medicine, 10000 Zagreb, Croatia.
Stingl Jankovic K; Tissue Typing Centre, Clinical Department for Transfusion Medicine and Transplantation Biology, University Hospital Centre Zagreb, 10000 Zagreb, Croatia.
Sestan M; Department of Pediatrics, University Hospital Centre Zagreb, University of Zagreb School of Medicine, 10000 Zagreb, Croatia.
Sapina M; Department of Pediatrics, University Hospital Centre Osijek, Josip Juraj Strossmayer University of Osijek, Medical Faculty Osijek, 31000 Osijek, Croatia.
Kifer N; Department of Pediatrics, University Hospital Centre Zagreb, University of Zagreb School of Medicine, 10000 Zagreb, Croatia.
Srsen S; Department of Pediatrics, University of Split School of Medicine, University Hospital Centre Split, 21000 Split, Croatia.
Frkovic M; Department of Pediatrics, University Hospital Centre Zagreb, University of Zagreb School of Medicine, 10000 Zagreb, Croatia.
Gagro A; Children's Hospital Zagreb, Medical Faculty Osijek, Josip Juraj Strossmayer University of Osijek, 10000 Zagreb, Croatia.
Grubic Z; Tissue Typing Centre, Clinical Department for Transfusion Medicine and Transplantation Biology, University Hospital Centre Zagreb, 10000 Zagreb, Croatia.
Jelusic M; Department of Pediatrics, University Hospital Centre Zagreb, University of Zagreb School of Medicine, 10000 Zagreb, Croatia.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2024 Jan 10; Vol. 25 (2). Date of Electronic Publication: 2024 Jan 10.
Typ publikacji:
Journal Article
MeSH Terms:
HLA Antigens*/genetics
IgA Vasculitis*/genetics
Genetic Predisposition to Disease*
Child ; Humans ; HLA-A Antigens ; HLA-B Antigens ; HLA-DRB1 Chains/genetics
Czasopismo naukowe
Tytuł:
Antibody verification of HLA class I and class II eplets by human monoclonal HLA antibodies.
Autorzy:
Kramer CSM; Department of Immunology, Leiden University Medical Center, Leiden, The Netherlands.
Bezstarosti S; Department of Immunology, Leiden University Medical Center, Leiden, The Netherlands.; Department of Nephrology, Leiden University Medical Center, Leiden, The Netherlands.
Franke-van Dijk MEI; Department of Immunology, Leiden University Medical Center, Leiden, The Netherlands.
Vergunst M; Department of Immunology, Leiden University Medical Center, Leiden, The Netherlands.
Roelen DL; Department of Immunology, Leiden University Medical Center, Leiden, The Netherlands.
Uyar-Mercankaya M; Department of Immunology, Leiden University Medical Center, Leiden, The Netherlands.
Voogt-Bakker KH; Department of Immunology, Leiden University Medical Center, Leiden, The Netherlands.
Heidt S; Department of Immunology, Leiden University Medical Center, Leiden, The Netherlands.
Pokaż więcej
Źródło:
HLA [HLA] 2024 Jan; Vol. 103 (1), pp. e15345.
Typ publikacji:
Journal Article
MeSH Terms:
Antibodies, Monoclonal*
HLA-DR Antigens*
Humans ; Epitopes ; Alleles ; Tissue Donors ; HLA-B Antigens ; HLA Antigens ; Histocompatibility Testing ; Graft Rejection
Czasopismo naukowe
Tytuł:
Hepatitis B core-related antigen dynamics and risk of subsequent clinical relapses after nucleos(t)ide analog cessation.
Autorzy:
Tsai YN; Division of Gastroenterology and Hepatology, E-Da Cancer Hospital, I-Shou University, Kaohsiung, Taiwan.; School of Medicine, College of Medicine, I-Shou University, Kaohsiung, Taiwan.
Wu JL; Department of Public Health, National Cheng Kung University, College of Medicine, Tainan, Taiwan.
Tseng CH; Division of Gastroenterology and Hepatology, E-Da Cancer Hospital, I-Shou University, Kaohsiung, Taiwan.; School of Medicine, College of Medicine, I-Shou University, Kaohsiung, Taiwan.
Chen TH; Division of Gastroenterology and Hepatology, E-Da Hospital, I-Shou University, Kaohsiung, Taiwan.
Wu YL; Division of Gastroenterology and Hepatology, E-Da Hospital, I-Shou University, Kaohsiung, Taiwan.
Chen CC; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Department of Internal Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.
Fang YJ; Department of Internal Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.; Department of Internal Medicine, National Taiwan University Hospital, Yun-Lin Branch, Yun-Lin, Taiwan.
Yang TH; Division of Gastroenterology, Department of Medicine, Lotung Poh-Ai Hospital, Yilan, Taiwan.
Nguyen MH; Division of Gastroenterology and Hepatology, Stanford University Medical Center, Palo Alto, CA, USA.; Department of Epidemiology and Population Health, Stanford University Medical Center, Palo Alto, CA, USA.
Lin JT; Division of Gastroenterology and Hepatology, E-Da Hospital, I-Shou University, Kaohsiung, Taiwan.
Hsu YC; School of Medicine, College of Medicine, I-Shou University, Kaohsiung, Taiwan.; Division of Gastroenterology and Hepatology, E-Da Hospital, I-Shou University, Kaohsiung, Taiwan.
Pokaż więcej
Źródło:
Clinical and molecular hepatology [Clin Mol Hepatol] 2024 Jan; Vol. 30 (1), pp. 98-108. Date of Electronic Publication: 2023 Dec 14.
Typ publikacji:
Multicenter Study; Journal Article
MeSH Terms:
Hepatitis B Core Antigens*
Hepatitis B, Chronic*/complications
Hepatitis B, Chronic*/drug therapy
Adult ; Humans ; Male ; Middle Aged ; Female ; Hepatitis B Surface Antigens ; Antiviral Agents/therapeutic use ; Hepatitis B e Antigens ; DNA, Viral ; Recurrence ; Hepatitis B virus/genetics
Czasopismo naukowe
Tytuł:
Instability of the HLA-E peptidome of HIV presents a major barrier to therapeutic targeting.
Autorzy:
Wallace Z; Immunocore Ltd., Abingdon, Oxfordshire OX14 4RY, UK. Electronic address: .
Heunis T; Immunocore Ltd., Abingdon, Oxfordshire OX14 4RY, UK.
Paterson RL; Immunocore Ltd., Abingdon, Oxfordshire OX14 4RY, UK.
Suckling RJ; Immunocore Ltd., Abingdon, Oxfordshire OX14 4RY, UK.
Grant T; Immunocore Ltd., Abingdon, Oxfordshire OX14 4RY, UK.
Dembek M; Immunocore Ltd., Abingdon, Oxfordshire OX14 4RY, UK.
Donoso J; Immunocore Ltd., Abingdon, Oxfordshire OX14 4RY, UK.
Brener J; Immunocore Ltd., Abingdon, Oxfordshire OX14 4RY, UK.
Long J; Immunocore Ltd., Abingdon, Oxfordshire OX14 4RY, UK.
Bunjobpol W; Immunocore Ltd., Abingdon, Oxfordshire OX14 4RY, UK.
Gibbs-Howe D; Immunocore Ltd., Abingdon, Oxfordshire OX14 4RY, UK.
Kay DP; Immunocore Ltd., Abingdon, Oxfordshire OX14 4RY, UK.
Leneghan DB; Immunocore Ltd., Abingdon, Oxfordshire OX14 4RY, UK.
Godinho LF; Immunocore Ltd., Abingdon, Oxfordshire OX14 4RY, UK.
Walker A; Immunocore Ltd., Abingdon, Oxfordshire OX14 4RY, UK.
Singh PK; Immunocore Ltd., Abingdon, Oxfordshire OX14 4RY, UK.
Knox A; Immunocore Ltd., Abingdon, Oxfordshire OX14 4RY, UK.
Leonard S; Immunocore Ltd., Abingdon, Oxfordshire OX14 4RY, UK.
Dorrell L; Immunocore Ltd., Abingdon, Oxfordshire OX14 4RY, UK.
Pokaż więcej
Źródło:
Molecular therapy : the journal of the American Society of Gene Therapy [Mol Ther] 2024 Mar 06; Vol. 32 (3), pp. 678-688. Date of Electronic Publication: 2024 Jan 12.
Typ publikacji:
Journal Article
MeSH Terms:
HLA-E Antigens*
HIV Infections*/therapy
Humans ; Histocompatibility Antigens Class I/genetics ; Histocompatibility Antigens Class I/metabolism ; Epitopes ; Peptides/metabolism
Czasopismo naukowe
Tytuł:
Costimulatory receptors in the channel catfish: CD28 family members and their ligands.
Autorzy:
Quiniou SMA; USDA-ARS-WARU, 141 Experiment Station Rd, 38776, Stoneville, MS, USA. .
Bengtén E; Center for Immunology and Microbial Research, University of Mississippi Medical Center, 39216, Jackson, MS, USA.; Department of Cell and Molecular Biology, University of Mississippi Medical Center, 39216, Jackson, MS, USA.
Boudinot P; Université Paris-Saclay, INRAE, UVSQ, VIM, Jouy-en-Josas, 78350, France. .
Pokaż więcej
Źródło:
Immunogenetics [Immunogenetics] 2024 Feb; Vol. 76 (1), pp. 51-67. Date of Electronic Publication: 2024 Jan 10.
Typ publikacji:
Journal Article
MeSH Terms:
CD28 Antigens*/genetics
CD28 Antigens*/metabolism
Ictaluridae*/genetics
Ictaluridae*/metabolism
Animals ; Humans ; CTLA-4 Antigen ; Antigens, CD ; B7-1 Antigen/genetics ; B7-1 Antigen/metabolism ; Ligands ; Cell Adhesion Molecules ; Phosphatidylinositol 3-Kinases ; Mammals
Czasopismo naukowe
Tytuł:
Molecular Signature of Monocytes Shaped by the Shigella sonnei 1790-Generalized Modules for Membrane Antigens Vaccine.
Autorzy:
Tondi S; Preclinical Research & Development, GSK, 53100 Siena, Italy.; Department of Life Sciences, University of Siena, 53100 Siena, Italy.
Siena E; Preclinical Research & Development, GSK, 53100 Siena, Italy.
Essaghir A; Preclinical Research & Development, GSK, 53100 Siena, Italy.
Bozzetti B; Preclinical Research & Development, GSK, 1330 Rixensart, Belgium.
Bechtold V; Preclinical Research & Development, GSK, 1330 Rixensart, Belgium.
Scaillet A; Preclinical Research & Development, GSK, 1330 Rixensart, Belgium.
Clemente B; Preclinical Research & Development, GSK, 53100 Siena, Italy.
Marrocco M; Preclinical Research & Development, GSK, 53100 Siena, Italy.; Department of Life Sciences, University of Siena, 53100 Siena, Italy.
Sammicheli C; Preclinical Research & Development, GSK, 53100 Siena, Italy.
Tavarini S; Preclinical Research & Development, GSK, 53100 Siena, Italy.
Micoli F; GSK Vaccines Institute for Global Health S.R.L. (GVGH), 53100 Siena, Italy.
Oldrini D; GSK Vaccines Institute for Global Health S.R.L. (GVGH), 53100 Siena, Italy.
Pezzicoli A; Preclinical Research & Development, GSK, 53100 Siena, Italy.
Di Fede M; Preclinical Research & Development, GSK, 53100 Siena, Italy.
Brazzoli M; Preclinical Research & Development, GSK, 53100 Siena, Italy.
Ulivieri C; Department of Life Sciences, University of Siena, 53100 Siena, Italy.
Schiavetti F; Preclinical Research & Development, GSK, 53100 Siena, Italy.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2024 Jan 17; Vol. 25 (2). Date of Electronic Publication: 2024 Jan 17.
Typ publikacji:
Journal Article
MeSH Terms:
Vaccines*
Blood Group Antigens*
Gastroenteritis*
Methylmethacrylates*
Humans ; Monocytes ; Shigella sonnei/genetics ; Antigens, Bacterial/genetics
Czasopismo naukowe
Tytuł:
Convergent synthesis of functionalized derivatives of stage-specific embryonic antigens 3 & 4.
Autorzy:
Pal R; Institute for Glyco-core Research (iGCORE), Gifu University, 1-1 Yanagido, Gifu, 501-1193, Japan; Institute for Integrated Cell-Material Sciences, Kyoto University, Kyoto, 606-8501, Japan.
Yamazaki A; Department of Applied Bioorganic Chemistry, Gifu University, 1-1 Yanagido, Gifu, 501-1193, Japan.
Komura N; Institute for Glyco-core Research (iGCORE), Gifu University, 1-1 Yanagido, Gifu, 501-1193, Japan; Institute for Integrated Cell-Material Sciences, Kyoto University, Kyoto, 606-8501, Japan. Electronic address: .
Tanaka HN; Institute for Glyco-core Research (iGCORE), Gifu University, 1-1 Yanagido, Gifu, 501-1193, Japan.
Imamura A; Institute for Glyco-core Research (iGCORE), Gifu University, 1-1 Yanagido, Gifu, 501-1193, Japan; Department of Applied Bioorganic Chemistry, Gifu University, 1-1 Yanagido, Gifu, 501-1193, Japan.
Ishida H; Institute for Glyco-core Research (iGCORE), Gifu University, 1-1 Yanagido, Gifu, 501-1193, Japan; Department of Applied Bioorganic Chemistry, Gifu University, 1-1 Yanagido, Gifu, 501-1193, Japan.
Ando H; Institute for Glyco-core Research (iGCORE), Gifu University, 1-1 Yanagido, Gifu, 501-1193, Japan; Institute for Integrated Cell-Material Sciences, Kyoto University, Kyoto, 606-8501, Japan. Electronic address: .
Pokaż więcej
Źródło:
Carbohydrate research [Carbohydr Res] 2024 Jan; Vol. 535, pp. 108990. Date of Electronic Publication: 2023 Nov 25.
Typ publikacji:
Journal Article
MeSH Terms:
Antigens, Tumor-Associated, Carbohydrate*
Carbohydrates*
Stage-Specific Embryonic Antigens ; Polysaccharides ; Lewis X Antigen
Czasopismo naukowe
Tytuł:
Structure-guided discovery of aminopeptidase ERAP1 variants capable of processing antigens with novel PC anchor specificities.
Autorzy:
Pande S; Department of Biological Sciences, University of Massachusetts Lowell, Lowell, Massachusetts, USA.; Molecular Cardiology Research Institute, Tufts Medical Center, Boston, Massachusetts, USA.
Guo HC; Department of Biological Sciences, University of Massachusetts Lowell, Lowell, Massachusetts, USA.
Pokaż więcej
Źródło:
Immunology [Immunology] 2024 Jan; Vol. 171 (1), pp. 131-145. Date of Electronic Publication: 2023 Oct 19.
Typ publikacji:
Journal Article
MeSH Terms:
Aminopeptidases*/genetics
Aminopeptidases*/chemistry
Aminopeptidases*/metabolism
Antigens*/metabolism
Humans ; Peptides/metabolism ; Minor Histocompatibility Antigens/genetics ; Minor Histocompatibility Antigens/metabolism ; Antigen Presentation
Czasopismo naukowe
Tytuł:
Seroreactivity of antibodies to hepatitis B core antigen among hepatitis B surface antigen-screened negative blood donors and its implications for blood safety in a resource-constrained country.
Autorzy:
Yu RT; Research Institute for Tropical Medicine, Muntinlupa City, Philippines.
Punzalan KAP; Research Institute for Tropical Medicine, Muntinlupa City, Philippines.
Bhatnagar S; Abbott Laboratories Singapore Pte Ltd., Singapore.
Lutero RB; Research Institute for Tropical Medicine, Muntinlupa City, Philippines.
Chamen IMS; Research Institute for Tropical Medicine, Muntinlupa City, Philippines.
Masangkay CB; Research Institute for Tropical Medicine, Muntinlupa City, Philippines.
Arcellana-Nuqui EY; National Council for Blood Services, Department of Health, Manila, Philippines.
Pokaż więcej
Źródło:
Vox sanguinis [Vox Sang] 2024 Mar; Vol. 119 (3), pp. 252-256. Date of Electronic Publication: 2024 Jan 21.
Typ publikacji:
Journal Article
MeSH Terms:
Hepatitis B Core Antigens*
Hepatitis B*/diagnosis
Humans ; Hepatitis B Surface Antigens ; Blood Safety ; Blood Donors ; DNA, Viral ; Hepatitis B virus/genetics ; Hepatitis B Antibodies ; Immunoglobulin M
Czasopismo naukowe
Tytuł:
Delivery of loaded MR1 monomer results in efficient ligand exchange to host MR1 and subsequent MR1T cell activation.
Autorzy:
Kulicke CA; Division of Pulmonary, Allergy, and Critical Care Medicine, Oregon Health & Science University, Portland, OR, 97239, USA.
Swarbrick GM; Division of Infectious Diseases, Department of Pediatrics, Oregon Health & Science University, Portland, OR, 97239, USA.
Ladd NA; Department of Biochemistry and Molecular Biology, University of Chicago, Chicago, IL, 60637, USA.
Cansler M; Division of Infectious Diseases, Department of Pediatrics, Oregon Health & Science University, Portland, OR, 97239, USA.
Null M; Division of Infectious Diseases, Department of Pediatrics, Oregon Health & Science University, Portland, OR, 97239, USA.
Worley A; Division of Pulmonary, Allergy, and Critical Care Medicine, Oregon Health & Science University, Portland, OR, 97239, USA.
Lemon C; Division of Pulmonary, Allergy, and Critical Care Medicine, Oregon Health & Science University, Portland, OR, 97239, USA.
Ahmed T; Division of Infectious Diseases, Department of Pediatrics, Oregon Health & Science University, Portland, OR, 97239, USA.
Bennett J; Division of Infectious Diseases, Department of Pediatrics, Oregon Health & Science University, Portland, OR, 97239, USA.
Lust TN; Division of Pulmonary, Allergy, and Critical Care Medicine, Oregon Health & Science University, Portland, OR, 97239, USA.
Heisler CM; Division of Pulmonary, Allergy, and Critical Care Medicine, Oregon Health & Science University, Portland, OR, 97239, USA.
Huber ME; Department of Molecular Microbiology and Immunology, Oregon Health & Science University, Portland, OR, 97239, USA.
Krawic JR; Department of Microbiology and Immunology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 73104, USA.
Ankley LM; Department of Microbiology and Molecular Genetics, College of Osteopathic Medicine, Michigan State University, East Lansing, MI, 48824, USA.
McBride SK; Department of Molecular Microbiology and Immunology, Oregon Health & Science University, Portland, OR, 97239, USA.
Tafesse FG; Department of Molecular Microbiology and Immunology, Oregon Health & Science University, Portland, OR, 97239, USA.
Olive AJ; Department of Microbiology and Molecular Genetics, College of Osteopathic Medicine, Michigan State University, East Lansing, MI, 48824, USA.
Hildebrand WH; Department of Microbiology and Immunology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 73104, USA.
Lewinsohn DA; Division of Infectious Diseases, Department of Pediatrics, Oregon Health & Science University, Portland, OR, 97239, USA.
Adams EJ; Department of Biochemistry and Molecular Biology, University of Chicago, Chicago, IL, 60637, USA.
Lewinsohn DM; Division of Pulmonary, Allergy, and Critical Care Medicine, Oregon Health & Science University, Portland, OR, 97239, USA.; VA Portland Health Care System, Portland, OR, 97239, USA.
Harriff MJ; Division of Pulmonary, Allergy, and Critical Care Medicine, Oregon Health & Science University, Portland, OR, 97239, USA. .; Department of Molecular Microbiology and Immunology, Oregon Health & Science University, Portland, OR, 97239, USA. .; VA Portland Health Care System, Portland, OR, 97239, USA. .
Pokaż więcej
Źródło:
Communications biology [Commun Biol] 2024 Feb 24; Vol. 7 (1), pp. 228. Date of Electronic Publication: 2024 Feb 24.
Typ publikacji:
Journal Article
MeSH Terms:
Histocompatibility Antigens Class I*/metabolism
Lymphocyte Activation*
Ribitol/*analogs & derivatives
Uracil/*analogs & derivatives
Ligands ; Antigen Presentation ; Antigens/metabolism
Czasopismo naukowe
Tytuł:
Characteristics and clinical treatment outcomes of chronic hepatitis B children with coexistence of hepatitis B surface antigen (HBsAg) and antibodies to HBsAg.
Autorzy:
Gu Y; Department of Maternal and Child Health, Xiangya School of Public Health, Central South University, No. 172 Tongzipo Road, Yuelu District, Changsha, Hunan, 410078, China.
Li S; Liver Disease Center, Hunan Children's Hospital, Changsha, 410000, China.
Yao Z; Department of Maternal and Child Health, Xiangya School of Public Health, Central South University, No. 172 Tongzipo Road, Yuelu District, Changsha, Hunan, 410078, China.
Lai X; Department of Maternal and Child Health, Xiangya School of Public Health, Central South University, No. 172 Tongzipo Road, Yuelu District, Changsha, Hunan, 410078, China.
Yang M; Department of Maternal and Child Health, Xiangya School of Public Health, Central South University, No. 172 Tongzipo Road, Yuelu District, Changsha, Hunan, 410078, China.
Xu Y; Department of Maternal and Child Health, Xiangya School of Public Health, Central South University, No. 172 Tongzipo Road, Yuelu District, Changsha, Hunan, 410078, China.
Peng S; Department of Maternal and Child Health, Xiangya School of Public Health, Central South University, No. 172 Tongzipo Road, Yuelu District, Changsha, Hunan, 410078, China. .
Pokaż więcej
Źródło:
BMC medicine [BMC Med] 2024 Feb 20; Vol. 22 (1), pp. 77. Date of Electronic Publication: 2024 Feb 20.
Typ publikacji:
Journal Article
MeSH Terms:
Hepatitis B Surface Antigens*/therapeutic use
Hepatitis B, Chronic*/drug therapy
Hepatitis B, Chronic*/epidemiology
Child ; Humans ; Child, Preschool ; Hepatitis B e Antigens/therapeutic use ; Retrospective Studies ; Hepatitis B virus ; Treatment Outcome ; Hepatitis B Antibodies/therapeutic use ; Antiviral Agents/therapeutic use
Czasopismo naukowe
Tytuł:
The B7:CD28 family and friends: Unraveling coinhibitory interactions.
Autorzy:
Burke KP; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA 02115, USA; Department of Immunology, Harvard Medical School, Boston, MA 02115, USA.
Chaudhri A; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA 02115, USA.
Freeman GJ; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA 02115, USA.
Sharpe AH; Department of Immunology, Harvard Medical School, Boston, MA 02115, USA; Broad Institute of MIT and Harvard, Cambridge, MA, USA; Brigham and Women's Hospital, Boston, MA 02115, USA. Electronic address: arlene_.
Pokaż więcej
Źródło:
Immunity [Immunity] 2024 Feb 13; Vol. 57 (2), pp. 223-244.
Typ publikacji:
Journal Article; Review
MeSH Terms:
CD28 Antigens*/metabolism
Autoimmune Diseases*
Humans ; Friends ; T-Lymphocytes ; CTLA-4 Antigen/metabolism ; Immunotherapy ; B7-1 Antigen/metabolism ; Immunoglobulins/metabolism ; Butyrophilins/metabolism ; Antigens, CD/metabolism
Czasopismo naukowe
Tytuł:
Targeting CD38/ ADP-ribosyl cyclase as a novel therapeutic strategy for identification of three potent agonists for leukopenia treatment.
Autorzy:
Liu Y; Division of Clinical Microscopy, Department of Medical Technology, Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai 50200, Thailand; Department of Pharmacy, The Affiliated Hospital, Southwest Medical University, Luzhou, Sichuan 646000, China; School of Basic Medical Sciences, Southwest Medical University, Luzhou, Sichuan 646000, China.
Zhang L; State Key Laboratory of Southwestern Chinese Medicine Resources, School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan 611137, China.
Wang L; School of Pharmacy, Southwest Medical University, Luzhou, Sichuan 646000, China; Laboratory for Drug Discovery and Druggability Evaluation of Sichuan Province, Luzhou Key Laboratory of Activity Screening and Druggability Evaluation for Chinese Materia Medica, Southwest Medical University, Luzhou, Sichuan 646000, China.
Tang X; School of Pharmacy, Southwest Medical University, Luzhou, Sichuan 646000, China; Laboratory for Drug Discovery and Druggability Evaluation of Sichuan Province, Luzhou Key Laboratory of Activity Screening and Druggability Evaluation for Chinese Materia Medica, Southwest Medical University, Luzhou, Sichuan 646000, China.
Wan S; Department of Pharmacy, The Affiliated Hospital, Southwest Medical University, Luzhou, Sichuan 646000, China; School of Pharmacy, Southwest Medical University, Luzhou, Sichuan 646000, China.
Huang Q; School of Pharmacy, Southwest Medical University, Luzhou, Sichuan 646000, China; Laboratory for Drug Discovery and Druggability Evaluation of Sichuan Province, Luzhou Key Laboratory of Activity Screening and Druggability Evaluation for Chinese Materia Medica, Southwest Medical University, Luzhou, Sichuan 646000, China.
Ran M; School of Pharmacy, Southwest Medical University, Luzhou, Sichuan 646000, China; Laboratory for Drug Discovery and Druggability Evaluation of Sichuan Province, Luzhou Key Laboratory of Activity Screening and Druggability Evaluation for Chinese Materia Medica, Southwest Medical University, Luzhou, Sichuan 646000, China.
Shen H; The Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University, Luzhou, Sichuan 646000, China.
Yang Y; Laboratory for Drug Discovery and Druggability Evaluation of Sichuan Province, Luzhou Key Laboratory of Activity Screening and Druggability Evaluation for Chinese Materia Medica, Southwest Medical University, Luzhou, Sichuan 646000, China.
Chiampanichayakul S; Division of Clinical Microscopy, Department of Medical Technology, Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai 50200, Thailand; Center of Excellence in Pharmaceutical Nanotechnology, Chiang Mai University, Chiang Mai 50200, Thailand.
Tima S; Division of Clinical Microscopy, Department of Medical Technology, Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai 50200, Thailand; Center of Excellence in Pharmaceutical Nanotechnology, Chiang Mai University, Chiang Mai 50200, Thailand.
Anuchapreeda S; Division of Clinical Microscopy, Department of Medical Technology, Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai 50200, Thailand; Center of Excellence in Pharmaceutical Nanotechnology, Chiang Mai University, Chiang Mai 50200, Thailand. Electronic address: .
Wu J; School of Basic Medical Sciences, Southwest Medical University, Luzhou, Sichuan 646000, China; Laboratory for Drug Discovery and Druggability Evaluation of Sichuan Province, Luzhou Key Laboratory of Activity Screening and Druggability Evaluation for Chinese Materia Medica, Southwest Medical University, Luzhou, Sichuan 646000, China. Electronic address: .
Pokaż więcej
Źródło:
Pharmacological research [Pharmacol Res] 2024 Feb; Vol. 200, pp. 107068. Date of Electronic Publication: 2024 Jan 15.
Typ publikacji:
Journal Article
MeSH Terms:
Antigens, CD*/genetics
Leukopenia*/chemically induced
Leukopenia*/drug therapy
Humans ; Mice ; Animals ; ADP-ribosyl Cyclase/metabolism ; ADP-ribosyl Cyclase 1 ; Antigens, Differentiation/genetics ; Membrane Glycoproteins ; Zebrafish/metabolism
Czasopismo naukowe
Tytuł:
Differentiating patient characteristics between platelet refractory patients with and without antibodies to human leukocyte antigens.
Autorzy:
Liu K; Department of Pathology and Laboratory Medicine, University of California San Francisco, San Francisco, California, USA.
Stephens L; Department of Pathology, University of California San Diego, San Diego, California, USA.
Nedelcu E; Department of Laboratory Medicine, University of California San Francisco, San Francisco, California, USA.
Bakhtary S; Department of Laboratory Medicine, University of California San Francisco, San Francisco, California, USA.
Pokaż więcej
Źródło:
Transfusion [Transfusion] 2024 Feb; Vol. 64 (2), pp. 210-215. Date of Electronic Publication: 2024 Jan 03.
Typ publikacji:
Journal Article
MeSH Terms:
Thrombocytopenia*
Antigens, Human Platelet*
Pregnancy ; Humans ; Female ; Platelet Transfusion/adverse effects ; Blood Platelets ; Blood Transfusion ; HLA Antigens ; Isoantibodies
Czasopismo naukowe
Tytuł:
The correlation between soluble human leukocyte antigen (sHLA-G) levels and +3010 polymorphism.
Autorzy:
Alyami A; Pathology and Clinical Laboratory Medicine Administration, King Fahad Medical City, Riyadh Second Health Cluster, Riyadh, Saudi Arabia.
AlJurayyan A; Pathology and Clinical Laboratory Medicine Administration, King Fahad Medical City, Riyadh Second Health Cluster, Riyadh, Saudi Arabia.
Alosaimi B; Research Center, King Fahad Medical City Riyadh Second Health Cluster, Riyadh, Saudi Arabia.
Alkadi H; Research Center, King Fahad Medical City Riyadh Second Health Cluster, Riyadh, Saudi Arabia.
Alkhulaifi F; College of Science, Imam Abdulrahman bin Faisal University, Dammam, Saudi Arabia.
Al-Jurayb H; Pathology and Clinical Laboratory Medicine Administration, King Fahad Medical City, Riyadh Second Health Cluster, Riyadh, Saudi Arabia.
Osman A; Pathology and Clinical Laboratory Medicine Administration, King Fahad Medical City, Riyadh Second Health Cluster, Riyadh, Saudi Arabia.
Christmas S; Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, UK.
Alomar S; College of Science, King Saud University, Riyadh, Saudi Arabia.
Al-Bayati Z; Department of Genetic Study, Azadi Teaching Hospital, Kirkuk, Iraq.
Pokaż więcej
Źródło:
International journal of immunogenetics [Int J Immunogenet] 2024 Feb; Vol. 51 (1), pp. 39-46. Date of Electronic Publication: 2023 Dec 12.
Typ publikacji:
Journal Article
MeSH Terms:
HLA-G Antigens*/genetics
Polymorphism, Single Nucleotide*
Humans ; Genotype ; 3' Untranslated Regions/genetics ; Histocompatibility Antigens Class II/genetics ; Gene Frequency
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies